19Indexed trials
mesh condition
Status Epilepticus
Intelligence
Status Epilepticus intelligence: 19 indexed trials, 4 recruiting studies, 16 sponsors across 20 countries.
4Recruiting
16Sponsors
20Countries
Leading sponsors
Assistance Publique - Hôpitaux de Paris31 recruiting
Xuanwu Hospital, Beijing21 recruiting
Bio-Signal Group Corp.10 recruiting
Erasme University Hospital11 recruiting
Fudan University10 recruiting
Jie Liu10 recruiting
Marinus Pharmaceuticals10 recruiting
Mayo Clinic10 recruiting
PTC Therapeutics10 recruiting
Sohag University11 recruiting
University Children's Hospital, Zurich10 recruiting
University Hospital Center of Martinique10 recruiting
Geographic activity
France5trials
United States5trials
China4trials
Italy2trials
Switzerland2trials
United Kingdom2trials
Belgium2trials
Netherlands1trials
Norway1trials
Pakistan1trials
Poland1trials
Spain1trials
Leading interventions
Anti-seizure medication1trials
Any anti-epileptic and anesthetic therapy, excluding Ketamine and Perampanel1trials
Blood sampling, cerebrospinal fluid , post-mortem cerebral tissues (NA for the Group 3)1trials
Blood sampling, cerebrospinal fluid, stool sampling post-mortem cerebral tissues (NA for the Group 3)1trials
Clonazepam1trials
EEG Cap1trials
Exogenous ketone ester1trials
Fosphenytoin1trials
IV Ganaxolone active1trials
IV Placebo, non-active1trials
Intravenous Sodium Valproate1trials
Anti-epileptic drugs1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.